Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Body weight changes and clinical outcome in adults on antiretroviral therapy in countries with limited resources.

Veld DH, Van Griensven J, Colebunders R.

J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):e36-7. doi: 10.1097/QAI.0b013e3181f7e407. No abstract available.

PMID:
21931282
2.

Changes in weight and lean body mass during highly active antiretroviral therapy.

Shikuma CM, Zackin R, Sattler F, Mildvan D, Nyangweso P, Alston B, Evans S, Mulligan K; AIDS Clinical Trial Group 892 Team.

Clin Infect Dis. 2004 Oct 15;39(8):1223-30. Epub 2004 Sep 27.

PMID:
15486848
3.

Limited impact of highly active antiretroviral therapy in thrombocytopenia.

Miguez MJ, Burbano X, Archer H, Shor-Posner G.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):260-1. No abstract available.

PMID:
12045691
4.

Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?

Colebunders R, Florence E, Lynen L, Bouckenooghe A.

Int J STD AIDS. 2003 Jan;14(1):1-5. No abstract available.

PMID:
12590784
5.

Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia.

Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, Banda Y, Stringer JS.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):507-13. doi: 10.1097/QAI.0b013e3181b32baf.

6.

Nutritional status of HIV-positive individuals on free HAART treatment in a developing nation.

Obi SN, Ifebunandu NA, Onyebuchi AK.

J Infect Dev Ctries. 2010 Nov 24;4(11):745-9.

7.

Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans Frontières.

Tassie JM, Szumilin E, Calmy A, Goemaere E; Médecins Sans Frontières.

AIDS. 2003 Sep 5;17(13):1995-7.

PMID:
12960837
8.

Antiretroviral therapy where resources are limited.

Reynolds SJ, Bartlett JG, Quinn TC, Beyrer C, Bollinger RC.

N Engl J Med. 2003 May 1;348(18):1806-9. No abstract available.

9.

Cancer in resource-limited settings.

Krown SE.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):297-9. doi: 10.1097/QAI.0b013e31820c0b0f. No abstract available.

PMID:
21350363
10.

Acute schizophrenic symptoms as the initial manifestation of HIV infection that respond to highly active antiretroviral therapy.

Hashimoto T, Nishio M, Sakai T, Fujimoto K, Sato N, Endo T, Koike T.

Clin Infect Dis. 2006 Jun 1;42(11):1653-5. No abstract available.

PMID:
16652326
11.

Herpes zoster among HIV-infected patients in the highly active antiretroviral therapy era: Korean HIV cohort study.

Song JY, Lee JS, Jung HW, Choi HJ, Lee JS, Eom JS, Cheong HJ, Jung MH, Kim WJ.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):417-8. doi: 10.1097/QAI.0b013e3181b1d6dc. No abstract available.

PMID:
20190589
12.
13.

Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy.

Grappin M, Piroth L, Verges B, Sgro C, Mack G, Buisson M, Duong M, Chavanet P, Portier H.

AIDS. 2000 May 26;14(8):1070-2. No abstract available.

PMID:
10853996
14.

Antiretroviral therapy and tuberculosis: what's the connection and what's the way forward?

Date AA, Miller B.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):255-7. doi: 10.1097/QAI.0b013e31822204fa. No abstract available.

PMID:
21602692
15.

Persistence of stunting after highly active antiretroviral therapy in HIV-infected children in South India.

Devi NP, Chandrasekaran K, Bhavani PK, Thiruvalluvan C, Swaminathan S.

Indian Pediatr. 2011 Apr;48(4):333-4.

PMID:
21532108
16.
17.

Current perspectives in HIV therapeutics.

Okulicz JF.

Ann Allergy Asthma Immunol. 2011 Jul;107(1):12-3. doi: 10.1016/j.anai.2011.05.023. No abstract available.

PMID:
21704879
18.

Acute Guillain-Barré syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy.

Bani-Sadr F, Neuville S, Crassard I, Guihot A, Molina JM.

AIDS. 2002 Jul 26;16(11):1562. No abstract available.

PMID:
12131198
19.

HIV and sexual dysfunction.

Colebunders R, Florence E, Schrooten W, Enzlin P.

Int J STD AIDS. 2003 Jan;14(1):69. No abstract available.

PMID:
12590805
20.

Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.

Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A.

AIDS. 2000 Aug 18;14(12):1675-88. Review. No abstract available.

PMID:
10985303

Supplemental Content

Support Center